June 26, 2025 - 23:29

Glendale-based Clarios, a prominent car battery manufacturer, has unveiled plans to invest as much as $600 million in the establishment of a cutting-edge manufacturing technology and training center in the United States. This ambitious project aims to enhance the company's production capabilities while simultaneously fostering workforce development within the industry.
The new facility is expected to play a crucial role in advancing innovative battery technologies, particularly as the automotive sector increasingly shifts towards electric vehicles. By focusing on state-of-the-art manufacturing processes, Clarios aims to improve efficiency and sustainability in battery production, aligning with the growing demand for eco-friendly energy solutions.
In addition to boosting manufacturing capabilities, the training center will provide essential educational resources for employees, ensuring that they are equipped with the latest skills and knowledge required in a rapidly evolving market. This investment not only underscores Clarios' commitment to innovation but also highlights the importance of workforce training in supporting the future of the automotive battery industry.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...